Mar 25, 2021 / 01:00PM GMT
Sandra Coombs - Alkermes plc - Co-Head of IR
Good morning. Welcome to the 2021 Alkermes Investor Day, and thank you for joining us. I'm Sandy Coombs, Vice President of Investor Relations. I hope you find today's presentations informative.
During today's presentations, we will be making forward-looking statements based on our current expectations relating to, among other things, the company's future financial and operating performance; the potential therapeutic and commercial value of nemvaleukin and our other product candidates; advancement of our research and development programs; and our Value Enhancement Plan and broader corporate strategy. These forward-looking statements are neither promises nor guarantees and are subject to a high degree of uncertainty and risk. Please see Slide 2 of the investor presentation accompanying this webcast and our most recent annual report filed with the SEC for important risk factors that could cause our actual performance and results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or
Alkermes Plc Virtual Investor Day Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot